16-30 of 617
Beyond the Colonoscopy: New Screening Guidelines for Colorectal Cancer
Project Oncology®Beyond the Colonoscopy: New Screening Guidelines for Colorectal Cancer
Matt Birnholz, MD
Assessing Racial Disparities in Colorectal Cancer Screening
GI InsightsAssessing Racial Disparities in Colorectal Cancer Screening
Neilanjan Nandi, MD
Folasade P. May, MD, PhD, MPhil
Recapping the 2021 ACG Clinical Guidelines: What’s New in Colorectal Cancer Screening?
GI InsightsRecapping the 2021 ACG Clinical Guidelines: What’s New in Colorectal Cancer Screening?
Peter Buch, MD, FACG, AGAF, FACP
Aasma Shaukat, MD, MPH
Strategies for Increasing Colorectal Cancer Screening Rates
GI InsightsStrategies for Increasing Colorectal Cancer Screening Rates
Neilanjan Nandi, MD
Samir Shah, MD
Adenoma Detection Rate: A Prediction of Colorectal Cancer
GI InsightsAdenoma Detection Rate: A Prediction of Colorectal Cancer
Peter Buch, MD, FACG, AGAF, FACP
Aasma Shaukat, MD, MPH
Colorectal Cancer in Young Patients: A Multidisciplinary Approach
GI InsightsColorectal Cancer in Young Patients: A Multidisciplinary Approach
Peter Buch, MD, FACG, AGAF, FACP
David Liska, MD
- advertisement
Developments in Colorectal Cancer Screening: Cell-Free DNA Blood Testing
GI InsightsDevelopments in Colorectal Cancer Screening: Cell-Free DNA Blood Testing
Peter Buch, MD, FACG, AGAF, FACP
William Grady, MD
Cost Considerations for Colorectal Cancer Screening: Examining the Data
Clinician's RoundtableCost Considerations for Colorectal Cancer Screening: Examining the Data
Weighing the Environmental Impact of Colorectal Cancer Screening Methods
Clinician's RoundtableWeighing the Environmental Impact of Colorectal Cancer Screening Methods
Peter Buch, MD, FACG, AGAF, FACP
A. Mark Fendrick, MD
Addressing Barriers to Colorectal Cancer Screening in Rural Populations
Clinician's RoundtableAddressing Barriers to Colorectal Cancer Screening in Rural Populations
Peter Buch, MD, FACG, AGAF, FACP
Michael Dougherty, MD
Improving Colorectal Cancer Screening Rates: Strategies for Equitable Care
Clinician's RoundtableImproving Colorectal Cancer Screening Rates: Strategies for Equitable Care
Charles Turck, PharmD, BCPS, BCCCP
Jane McElroy, PhD
Jean Wang, MD, PhD
Nuha Wareg, MPH, MBBS
Colorectal Cancer Screening: Evaluating the Cost-Effectiveness of Noninvasive Options
Clinician's RoundtableColorectal Cancer Screening: Evaluating the Cost-Effectiveness of Noninvasive Options
Brian P. McDonough, MD, FAAFP
Carolyn Rutter, PhD
Gloria Coronado, PhD
- advertisement
ctDNA-Guided Adjuvant Atezolizumab in MIBC: IMvigor011 Insights
Project Oncology®ctDNA-Guided Adjuvant Atezolizumab in MIBC: IMvigor011 Insights
Charles Turck, PharmD, BCPS, BCCCP
Guru P. Sonpavde, MD
Repeat mt-sDNA Screening for Colorectal Cancer in Underserved Populations
Clinician's RoundtableRepeat mt-sDNA Screening for Colorectal Cancer in Underserved Populations
Early CRC Screening: Uptake Strong in Younger Adults Using Stool DNA Test
Clinician's RoundtableEarly CRC Screening: Uptake Strong in Younger Adults Using Stool DNA Test
